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Attention-deﬁcit/hyperactivity disorder (ADHD) is a highly heritable, heterogeneous disorder of early onset, consisting
of a triad of symptoms: inattention, hyperactivity, and impulsivity. The disorder has a signiﬁcant genetic component,
and theories of etiology include abnormalities in the dopaminergic system, with DRD4, DAT1, SNAP25, and DRD5
being implicated as major susceptibility genes. An initial report of association between ADHD and the common 148-
bp allele of a microsatellite marker located 18.5 kb from the DRD5 gene has been followed by several studies showing
nonsigniﬁcant trends toward association with the same allele. To establish the postulated association of the (CA)n
repeat with ADHD, we collected genotypic information from 14 independent samples of probands and their parents,
analyzed them individually and, in the absence of heterogeneity, analyzed them as a joint sample. The joint analysis
showed association with the DRD5 locus ( ; odds ratio 1.24; 95% conﬁdence interval 1.12–1.38). ThisPp .00005
association appears to be conﬁned to the predominantly inattentive and combined clinical subtypes.
Attention-deﬁcit/hyperactivity disorder (ADHD [MIM
143465]) is a common disorder of childhood onset that
manifests itself as a combination of inattentive, hy-
peractive, and impulsive symptoms. It is known to affect
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3%–9% of school-aged children worldwide (Faraone et
al., in press) and may often persist into adulthood (Far-
aone et al. 2000). The heritability of ADHD is estimated
to be 70%–90% (Levy et al. 1997; Thapar et al. 1999).
Children with this disorder often develop severe problems
with personal relationships and academic development.
Compared with control subjects, ADHD probands ex-
hibit lower grades, fail more courses, have worse perfor-
mance on standardized tests, have fewer friends, and are
rated less adequate in psychosocial adjustment (Man-
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Table 1
Information about Individual Groups
Group
Number
Primary
Investigator
No. of
Cases
Publication
Statusa
Origin of
Sample
Instrument
of Diagnosisb
1 C. J. Kratochvil 41 U United States KSADS
2 F. Levy 66 U Australia ATBRS
3 L. Kent 69 U United Kingdom CAPA
4 S. V. Faraone 82 U United States K-SADS-E
5 L. A. Rohde 85 U Brazil K-SADS-E
6 E. Tahir 100 Pc Turkey KSADS
7 P. Asherson 103 U United Kingdom CAPA
8 A. Thapar 106 Pd United Kingdom CAPA
9 R. D. Todd 161 U United States MAGIC
10 M. Gill 168 Pe  U Ireland CAPA
11 R. P. Ebstein 176 U Israel Clinical interview
12 C. L. Barr 178 Pf  U Canada PICS-IV
13 R. J. Sinke 207 U Holland DISC
14 S. L. Smalley 438 Pg United States K-SADS-PiL
a Up unpublished data; Pp previously published data; P  Up previously published data
with the addition of new unpublished data.
b KSADS p Kidi schedule for affective disorders and schizophrenia (Kaufman et al. 1997).
ATBRSpAustralian Twin Behavior Rating Scale (Hay et al. 2001). CAPApChild andAdolescent
Psychiatric Assessment (Angold et al. 1995). K-SADS-E p Schedule for Affective Disorders and
Schizophrenia for School-Age Children–Epidemiologic Version (Orvaschel et al. 1987). MAGIC
p Missouri Assessment of Genetics Interview for Children (Reich 2000). PICS-IV p Parent
Interview for Child Symptoms (A. Schachar, A. Ichowicz, unpublished data). DISCp Diagnostic
Interview Schedule for Children (Shaffer et al. 2000). K-SADS-PiLp Schedule for Affective Dis-
orders and Schizophrenia for School-Age-Children Present and Lifetime version (Kaufman et al.
1997).
c Tahir et al. (2000).
d Payton et al. (2001).
e Daly et al. (1999).
f Barr et al. (2000).
g Kustanovich et al. (in press).
nuzza and Klein 2000). In addition, individuals with this
disorder are at greater risk for substance abuse (Flory
et al. 2003). Furthermore, individuals with ADHD are
reported to have increased driving problems; as part of
a case-control study, individuals with ADHD self-re-
ported more trafﬁc citations—including, speeding, ve-
hicular crashes, and license suspensions—than their
counterparts in the control group (Barkley et al. 2002).
The exact etiology of ADHD is unknown, but it is
widely recognized to have a signiﬁcant genetic compo-
nent, as demonstrated by family (Biederman et al. 1992),
twin (Silberg et al. 1996), and adoption (Cadoret and
Stewart 1991) studies. Although both the serotonergic
and noradrenergic systems have been implicated in
ADHD, the dopaminergic system is by far the most ex-
tensively explored to date. Neuropharmacological studies
have demonstrated that methylphenidate and dexamphe-
tamine—stimulant medications that are effective in∼70%
of patients with ADHD (Spencer et al. 1996)—block the
reuptake of dopamine by the dopamine transporterDAT1
(Amara and Kuhar 1993; Krause et al. 2000). Neuroim-
aging studies have shown abnormalities in the frontal lobe
and subcortical structures, regions that are known to be
rich in dopaminergic neurotransmission and important in
the control of attention and response to organization (Lou
et al. 1990; Zametkin et al. 1990; Rubia et al. 1997).
Multiple animal models have been produced, including
the DAT1 knockout mouse, which expresses spontaneous
hyperactivity and difﬁculty with learning tasks (Davids et
al. 2003). In addition, molecular genetic studies have im-
plicated susceptibility genes, including those for the do-
pamine D4 receptor (DRD4), the dopamine transporter
(DAT1), dopamine b hydroxylase (DBH), synaptosomal
associated protein 25 (SNAP25), and the dopamine D5
receptor (DRD5).
To date, the most extensively examined genes of the
dopaminergic system are DRD4 and DAT1 (Hawi et al.
2003a). The primary focus of attention at DAT1 has been
the 480-bp allele of a 40-bp repeat located in the 3′ UTR
of the gene. In the case of DRD4, the majority of studies
have reported on a 48-bp microsatellite located in exon
3 of the gene and translated to the third intracellular loop
of the protein. Recently, meta-analyses have been per-
formed on both of these markers, in an attempt to deﬁn-
itively conﬁrm or refute associationwith ADHD (Faraone
et al. 2001; Maher et al. 2002).
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Figure 1 Funnel plot showing the number of affected offspring versus OR. The inverted funnel shape of this plot depicts results consistent
with the absence of publication bias. The solid line represents OR p 1, and the dotted line represents OR p 1.24.
In 1999, Daly et al. reported a signiﬁcant association
between ADHD and the 148-bp allele of a microsatelite
marker located 18.5 kb 5′ to the DRD5 gene on chromo-
some 4. Subsequent studies of this (CA)n repeat marker
have shown nonsigniﬁcant trends toward association
with the same allele (Barr et al. 2000; Tahir et al. 2000;
Payton et al. 2001). To avoid the premature conclusion
of the presence or absence of an association with ADHD
(and guided by the meta-analyses of DRD4 and DAT1),
a joint analysis of DRD5 was proposed. Although there
is no evidence to suggest that the D5 microsatellite is
itself functional, the association reported by Daly et al.
(1999) is too strong to be ignored. Therefore,wehypothe-
sized that if the association with ADHD were true, the
microsatellite may be in linkage disequilibrium (LD) with
one or more functional variants. To this end, we invited
all known groups with samples based on parent-proband
trios to genotype their sample for the marker and present
us with their data for analysis (table 1).
In the event of an overall signiﬁcant association be-
tween the variant and ADHD, we proposed that, owing
to the unique opportunity presented by a data set of this
magnitude, we would further examine the association
in relation to a number of different subdivisions. Three
times more males than females receive a diagnosis of
ADHD (Anderson et al. 1987), and it has been reported
by teachers that affected boys are more inattentive and
more hyperactive/impulsive than affected girls (Hartung
et al. 2002). Furthermore, Clarke et al. (2003) have re-
ported results indicating that girls with ADHD also ex-
hibit abnormalities in their electroencephalograms; how-
ever, there is far less variance in their proﬁles than appears
in boys. We therefore proposed analysis by the sex of the
affected child. In addition, we planned to examine the
sex of the transmitting parent, because the literature has
suggested the possibility of imprinting at theDRD2 (Kir-
ley et al. 2002) and SNAP-25 loci (Brophy et al. 2002)
in conjunction with multiple known imprinted genes in
various other areas of psychiatric genetics (Davies et al.
2001). Finally, recent attention has focused on more ho-
mogeneous diagnostic symptoms and subtypes. Wald-
man et al. (1998) reported that, in between-family as-
sociation analyses, levels of predominantly hyperactive-
impulsive symptoms were related to the number ofDAT1
high-risk alleles but that levels of the inattentive symp-
toms were not, whereas within-family analysis showed
association between DAT1 and the combined subtype.
We therefore also proposed to analyze the joint sample
in relation to diagnostic subtype.
All children in the present study were given a diagnosis
of one of the three clinical subtypes (predominantly in-
attentive, predominantly hyperactive/impulsive, or com-
bined) of ADHD, according to criteria of the Diagnostic
and Statistical Manual, fourth edition (DSM-IV) (Ameri-
can Psychiatric Association 1994). To receive a diagnosis
of predominantly inattentive or predominantly hyperac-
tive/impulsive ADHD, children must display a minimum
of six of the nine symptoms from the inattentive or hy-
peractive/impulsive sections of the DSM-IV in aminimum
of two settings (e.g., home and school). If a child has
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Figure 2 Regression of the standardized effect size versus the precision of the OR. The intercept of the line will occur close to 0, implying
no bias in the samples.
six or more symptoms in both sections, then he or she
receives a diagnosis of combined-type ADHD. Inclusion
criteria for the present study were the presence of a
DSM-IV diagnosis of childhood-onset ADHD and the
genotyping of one or both parents. Exclusion criteria
were the presence of pervasive developmental disorders,
fragile X syndrome, major neurological disorders, fetal
alcohol syndrome, Tourette syndrome, psychosis, and a
full-scale IQ score !70. Information on the sex of the
children was provided along with the clinical subtype.
Genotypic data for the microsatellite marker were col-
lected from each group, along with at least three DNA
samples, which were genotyped at the Neuropsychiatry
Genetics Laboratory, Dublin, to ensure consistent allele
calling between centers. The data received from each
group consisted of genotypes from affected probands
and either or both of their parents.
To obtain as complete a sample as possible—and to
avoid potential bias—we contacted all members of the
ADHD collaborative network (Faraone et al. 2003) and
invited their participation. We also searched PubMed
using the keywords “ADHD” and “DRD5.” This re-
vealed an earlier meta-analysis (Maher et al. 2002) that
contained data from four published studies, which we
have included, and from an additional unpublished sam-
ple, which we excluded because it did not meet our in-
clusion criteria. We are aware of ﬁve additional samples
that have not yet been genotyped for this marker. This
approach to sample collection should provide adequate
power to conﬁrm a gene of small effect and to minimize
publication bias. A funnel plot (Egger et al. 1997) was
produced to examine for evidence of sample bias in the
study. This was achieved by plotting the number of af-
fected children for each sample against its equivalent odds
ratio (OR), in conjunction with the OR for the combined
sample (ﬁg. 1). The larger samples should result in ORs
that are closer to the true OR than the smaller samples.
In addition, we regressed the normal SD of the OR
against the precision of the OR, according to the meth-
ods used by Egger et al. (1997) through use of STATA
6.0 (StataCorp 1999). This analysis works on the same
basis as the funnel plot, in that the precision of the OR
increases with sample size. Egger et al. (1997) showed
that, in the absence of bias, the regression would run
through the origin (ﬁg. 2). This method produces an
R2 (measure of the ﬁt of the regression to the data) and
a value for the intercept of the line, along with corre-
sponding statistics.
Initially, association analyses were performed on each
individual group’s sample, using the family-based ex-
tended transmission/disequilibrium test (ETDT) (Sham
and Curtis 1995). This test was designed to avoid popu-
lation stratiﬁcation by using parental genotypes as in-
ternal controls and to disregard duos whose inclusion
could potentially lead to bias (Curtis and Sham 1995).
It is adapted from the transmission/disequilibrium test
(TDT) and is used to examine for linkage in the presence
of association between multiallelic markers and disease
phenotypes. The analysis involves the comparison of
transmissions and nontransmissions of the risk allele
from heterozygous parents to affected offspring.
To test for heterogeneity among the samples, we used
the transmission and nontransmission information of the
148-bp allele from the TDT analysis. Two different lo-
gistic regression models were compared. The ﬁrst model
assumed homogeneity (i.e., that the regression coefﬁcients
were the same across studies, so only one regression co-
efﬁcient was estimated); the second model assumed het-
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Table 2
Individual Group Results
Group
Number
No. of
Affected
Cases
No. of
Parents
Allele
Rangea
Frequency
of Allele 10
(%) OR P
1 41 63 6–17 49.2 1.50 .44
2 66 82 7–17 35.1 1.05 .88
3 69 121 4–18 50.8 .72 .29
4 82 126 5–18 46.5 1.00 1.00
5 85 138 7–19 39.7 1.09 .77
6 100 193 4–17 39.8 1.34 .21
7 103 179 6–18 44.9 1.35 .28
8 106 233 6–18 43.2 1.25 .42
9 161 271 6–19 44.5 1.45 .05
10 168 325 6–17 43.6 1.57 .02
11 176 333 1–16 36.3 1.60 .004
12 178 268 5–17 46.4 1.15 .38
13 207 295 6–19 44.6 .95 .75
14 438 445 5–20 38.5 1.24 .05
Total 1,980 3,072 1–20 43.1 1.24 .00005
a Allele range: allele 1 p 166 bp, allele 20 p 128 bp, and allele
10 p 148 bp.
erogeneity (i.e., that all the regression coefﬁcients were
different, so that as many regression coefﬁcients were es-
timated as there were studies). Both models produced
a 2 log likelihood value, a measure that attempts to
assess the suitability of the statistical method used for
a given set of data. Using the formula (2 log
, we2likelihood ) (2 log likelihood )p xindividual combined
tested for evidence of a signiﬁcant difference between the
two models, which would be indicative of heterogeneity
among the samples.
For the sensitivity analysis, each group’s data were re-
moved in turn from the combined total, and the remaining
data were reanalyzed. This was performed to ensure that
no individual group was biasing the combined result.
The attributable fraction (Levin 1953) for the marker
was calculated according to the formula f(RR
, where f is the frequency of the 148-1)/[f(RR 1) 1]
bp allele in the sample of nontransmitted alleles and RR
is the relative risk. The value was calculated as RRp
, where a is the number of trans-[a/(a c)]/[b/(b d)]
missions of the risk allele, b is the number of nontrans-
missions of the risk allele, c is the number of transmis-
sions of the nonrisk alleles, and d is the number of non-
transmissions of the nonrisk alleles.
To test the combined sample for signiﬁcant differences
between the diagnostic subtype, the sex of the child, and
the sex of the transmitting parent, we ﬁrst performed
TDT analyses on the subsets of each group (e.g., a male
subset and a female subset for the group deﬁned by sex),
using the ETDT. The ORs calculated for each were then
weighted according to the number of cases in each subset
and were compared with each other by use of logistic
regression.
TDT analyses on the individual samples tested showed
a signiﬁcant association between the 148-bp allele and
two of the ADHD samples. The majority of the rest dis-
played an excess of transmission of the 148-bp allele but
did not attain statistical signiﬁcance. Two of the samples
showed a level of transmission of the 148-bp allele that
was less than the expected transmission (table 2; ﬁg. 3).
Despite these variations, the heterogeneity test failed to
detect the presence of heterogeneity between the 14 sam-
ples ( with 13 df; ). They were there-2x p 11.98 Pp .53
fore combined, and the joint analysis on this data set
(1,980 probands and 3,072 parents) indicated a strongly
signiﬁcant association of small effect ( with 12x p 16.45
df; ; ; 95% CI 1.12–1.38) be-Pp .00005 ORp 1.24
tween ADHD and the 148-bp allele of the microsatellite
marker. Sensitivity analysis (table 3) showed strong sig-
niﬁcance, regardless of the data set removed, with the P
value never 1.001 and the OR never ﬂuctuating 10.04 in
either direction from the combined result. The attribut-
able fraction was calculated using the frequency of the
148-bp allele among nontransmitted parental alleles as a
conservative estimate of population frequency and was
found to be 0.07.
In the funnel plot (ﬁg. 1), the larger samples displayed
ORs closer to that of the combined OR than did the
smaller samples, resulting in a visual representation of an
inverted funnel that is consistent with the absence of sam-
ple bias. The method described by Egger et al. (1997)
produced a scatter plot of the data with an R2 value of
0.8036 (ﬁg. 2), implying a good ﬁt of the data to the
line. The intercept was calculated to be 0.179 (SEp
; ; ; 95% CI 2.218645 to1.100245 tp 0.16 Pp .874
2.575809). According to Egger et al. (1997), in the ab-
sence of publication bias, the intercept of this line should
be 0. If bias exists, then the intercept should be signiﬁ-
cantly 10. Our intercept of 0.179 is not signiﬁcant and
is therefore consistent with the funnel plot in its implica-
tion that publication bias is absent from the sample.
We examined the association in relation to the sex of
the child, which was negative, and the sex of the trans-
mitting parent, which showed a trend toward a maternal
effect ( ; with 1 df; ) and the diagnostic2x p 2.6 Pp .11
subtype. The three clinical subtypes—predominantly in-
attentive ( ), combined ( ), and pre-np 445 np 1,106
dominantly hyperactive/impulsive ( )—were ex-np 122
amined separately and found to have ORs of 1.5, 1.3,
and 0.9, respectively, with corresponding P values of
.0001, .0001, and .6. Comparison between the individ-
ual ORs (table 4) indicated a signiﬁcant difference
( ) between the inattentive and hyperactive/im-Pp .035
pulsive subtypes.
Loci conferring risk with OR !1.5 require large sam-
ples for detection and replication (Dahlman et al. 2002).
In the ﬁeld of psychiatric genetics, this is difﬁcult to attain;
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Table 3
Sensitivity Analysis
Subtracted
Group OR 95% CI P
1 1.24 1.11 – 1.38 .00007
2 1.25 1.12 – 1.39 .00004
3 1.26 1.14 – 1.40 .00002
4 1.25 1.12 – 1.39 .00004
5 1.24 1.12 – 1.38 .00007
6 1.24 1.11 – 1.38 .00011
7 1.24 1.11 – 1.38 .00009
8 1.24 1.12 – 1.38 .00007
9 1.22 1.10 – 1.37 .00027
10 1.22 1.09 – 1.36 .00041
11 1.20 1.08 – 1.34 .00103
12 1.25 1.12 – 1.40 .00007
13 1.28 1.15 – 1.43 .00001
14 1.24 1.10 – 1.40 .00039
Totala 1.24 1.12 – 1.38 .00005
NOTE.—Results are shown for the joint
data set, with the subtraction of each group
in turn.
a Totals indicate results when no group is
subtracted.
Figure 3 ORs and respective 95% CIs for each sample, displayed in order of size, with the largest sample at the top. The solid line
represents an OR of 1, and the dotted line represents an OR of 1.24
consequently, there are multiple small studies of markers
without conclusive results. This has led to the introduction
of the combined, or meta-analysis, approach to this area
of genetics. The principal concerns in combining multiple
data sets are the possibility of heterogeneity between sam-
ples and the possibility of publication bias. In the present
study, we found no evidence of heterogeneity among the
samples and no publication bias, and we therefore com-
bined the data from all 14 groups.
Using the large combined sample, we have determined
that the OR for the DRD5 148-bp variant is 1.24; how-
ever, because the allele is common in the population, it
has an attributable fraction of 0.07. For complex disor-
ders involving the interaction of multiple genes and en-
vironmental factors, it is difﬁcult to attribute an individual
case to any single etiological factor. Nevertheless, the at-
tributable fraction is still a useful index of potential public
health importance, because it is deﬁned to be the frac-
tional reduction in the frequency of disease if the risk
factor were eliminated from the population. Sensitivity
analysis showed that the omission of any of the groups—
including that with the smallest P value (group 11), that
with the largest P value (group 13), or that containing
the original ﬁndings (group 10)—did little to alter the
overall results, implying that no one group’s data are
responsible for the combined result.
The existence of a single published result showing sig-
niﬁcant association between the 148-bp allele and ADHD
(Daly et al. 1999), coupled with a number of nonsig-
niﬁcant trends in the same direction (Barr et al. 2000;
Tahir et al. 2000; Payton et al. 2001), follows a pattern
familiar to researchers and others engaged in associa-
tion studies with small samples. It could have been
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Table 4
Logistic Regression Analysis Comparing ORs of the Diagnostic Subgroups
Comparison x2 P 95% CI
Predominantly inattentive vs. combined 1.287 .257 .902–1.471
Predominantly hyperactive/impulsive vs. combined 2.654 .103 .659–1.039
Predominantly inattentive vs. predominantly hyperactive/impulsive 4.468 .035 .367–.963
concluded, incorrectly, that the original result was a
false-positive ﬁnding. The present joint analysis, how-
ever, suggests that the original is a true ﬁnding of as-
sociation between ADHD and the polymorphism and
that individual sample sizes lacked sufﬁcient power for
conﬁrmation.
Subtype analyses indicate that the association of the
148-bp allele is selective for predominantly inattentive
and combined subtypes. It should be noted that although
the sample size for the predominantly hyperactive/im-
pulsive group is relatively small, the power of this sample
to detect association with the disorder was 175% (ap
) and 85% ( ). Whether the DRD5 associa-0.05 ap 0.1
tion is restricted to inattentive symptoms awaits further
study using QTL (Curran et al. 2001) or alternative sub-
typing approaches (Todd et al. 2001; Rasmussen et al.
2002).
The microsatellite marker is located 18.5 kb from the
transcription start site of the DRD5 gene, and no func-
tional role has been reported to date. This makes it an
unlikely, although not impossible, functional variant. It
is more probable that the microsatellite is in LD with
the true functional variant (or variants) located in (or
closer to) the DRD5 gene. In support of this theory, a
recent publication reported a signiﬁcant haplotype com-
posed of the 148-bp allele of this marker and another
microsatellite located at the 3′ UTR of the gene ( 2x p
; ) with a signiﬁcant LD between the14.208 Pp .00017
markers ( ) (Hawi et al. 2003b).′D p 0.519
In conclusion, the present study has shown that the
148-bp allele of this DRD5 microsatellite marker is as-
sociated with ADHD in a large combined homogeneous
international sample. It has also been indicated that the
association may be conﬁned to particular subtypes or
symptom traits, although we acknowledge that this ﬁnd-
ing requires additional conﬁrmation. We believe that the
results of this joint analysis will encourage efforts to iden-
tify the functional variant or variants of this gene and
will promote further collaboration in the ﬁeld of psychi-
atric genetics.
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